High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2001 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1413-86702001000300002 http://repositorio.unifesp.br/handle/11600/1178 |
Resumo: | Hepatitis C virus (HCV) causes infectious hepatitis worldwide. It is transmitted mainly by blood products and sharing of intravenous paraphernalia during illicit drug use. High prevalence rates have been described among specific groups considered to be at higher risk for HCV infection, including prison inmates. The objectives of this study were: to determine the HCV seroprevalence among inmates of Casa de Detenção de São Paulo; to identify risk factors for HCV infection; and to compare the seroprevalence of HCV to other blood borne or sexually transmitted diseases. From December, 1993, to January, 1994, a total of 779 inmates were interviewed to collect information on sociodemographic status, sexual behavior, and past experience with illicit drugs. Blood samples were obtained from 756 inmates for serological tests. 310 (41%) blood samples were positive for anti-HCV, 425 (56.2%) were negative, and 21 (2.8%) showed indeterminate results. In this population, we found a seroprevalence of 13.7% for HIV, 3.3% for syphilis (VDRL), and 68.1% for hepatitis B virus previous infection. Four variables were each identified as associated with a positive anti-HCV serologic test: a positive VDRL (OR = 2.63 IC 95% 1.08 to 6.36); a time of current imprisonment longer than 130 months (OR = 2.44 IC 95% 1.04 to 5.71); previous incarceration at Casa de Detenção de São Paulo (OR = 1.73 IC 95% 1.19 to 2.52) and; illicit drug use before admission to the Casa de Detenção de São Paulo (OR = 1.64 IC 95% 1.15 to 2.33). The seroprevalence of HCV antibodies among the study population was high (41%), indeed, one of the highest clusters of HCV infection recorded until now. Four variables were each shown to be associated with HCV infection. The simultaneous presence of these 4 variables is associated with an 82% probability of being anti-HCV positive. Although risk factor analysis indicates most HCV infections occur prior to inprisonment, initiation of control measures to prevent continued transmission after incarceration should be done. |
id |
UFSP_f3c79d4e840b4237152325304987f2a1 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/1178 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infectionHCVseroprevalenceprisonrisk factorHepatitis C virus (HCV) causes infectious hepatitis worldwide. It is transmitted mainly by blood products and sharing of intravenous paraphernalia during illicit drug use. High prevalence rates have been described among specific groups considered to be at higher risk for HCV infection, including prison inmates. The objectives of this study were: to determine the HCV seroprevalence among inmates of Casa de Detenção de São Paulo; to identify risk factors for HCV infection; and to compare the seroprevalence of HCV to other blood borne or sexually transmitted diseases. From December, 1993, to January, 1994, a total of 779 inmates were interviewed to collect information on sociodemographic status, sexual behavior, and past experience with illicit drugs. Blood samples were obtained from 756 inmates for serological tests. 310 (41%) blood samples were positive for anti-HCV, 425 (56.2%) were negative, and 21 (2.8%) showed indeterminate results. In this population, we found a seroprevalence of 13.7% for HIV, 3.3% for syphilis (VDRL), and 68.1% for hepatitis B virus previous infection. Four variables were each identified as associated with a positive anti-HCV serologic test: a positive VDRL (OR = 2.63 IC 95% 1.08 to 6.36); a time of current imprisonment longer than 130 months (OR = 2.44 IC 95% 1.04 to 5.71); previous incarceration at Casa de Detenção de São Paulo (OR = 1.73 IC 95% 1.19 to 2.52) and; illicit drug use before admission to the Casa de Detenção de São Paulo (OR = 1.64 IC 95% 1.15 to 2.33). The seroprevalence of HCV antibodies among the study population was high (41%), indeed, one of the highest clusters of HCV infection recorded until now. Four variables were each shown to be associated with HCV infection. The simultaneous presence of these 4 variables is associated with an 82% probability of being anti-HCV positive. Although risk factor analysis indicates most HCV infections occur prior to inprisonment, initiation of control measures to prevent continued transmission after incarceration should be done.Federal University of São Paulo Medical CollegeUNIFESP, Medical CollegeSciELOBrazilian Society of Infectious DiseasesUniversidade Federal de São Paulo (UNIFESP)Guimarães, Thaís [UNIFESP]Granato, Celso Francisco Hernandes [UNIFESP]Varella, Drauzio [UNIFESP]Ferraz, Maria Lucia Cardoso Gomes [UNIFESP]Castelo Filho, Adauto [UNIFESP]Kallas, Esper Georges [UNIFESP]2015-06-14T13:29:25Z2015-06-14T13:29:25Z2001-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion111-118application/pdfhttp://dx.doi.org/10.1590/S1413-86702001000300002Brazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 5, n. 3, p. 111-118, 2001.10.1590/S1413-86702001000300002S1413-86702001000300002.pdf1413-8670S1413-86702001000300002http://repositorio.unifesp.br/handle/11600/1178engBrazilian Journal of Infectious Diseasesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-29T23:28:34Zoai:repositorio.unifesp.br/:11600/1178Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-29T23:28:34Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
title |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
spellingShingle |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection Guimarães, Thaís [UNIFESP] HCV seroprevalence prison risk factor |
title_short |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
title_full |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
title_fullStr |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
title_full_unstemmed |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
title_sort |
High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection |
author |
Guimarães, Thaís [UNIFESP] |
author_facet |
Guimarães, Thaís [UNIFESP] Granato, Celso Francisco Hernandes [UNIFESP] Varella, Drauzio [UNIFESP] Ferraz, Maria Lucia Cardoso Gomes [UNIFESP] Castelo Filho, Adauto [UNIFESP] Kallas, Esper Georges [UNIFESP] |
author_role |
author |
author2 |
Granato, Celso Francisco Hernandes [UNIFESP] Varella, Drauzio [UNIFESP] Ferraz, Maria Lucia Cardoso Gomes [UNIFESP] Castelo Filho, Adauto [UNIFESP] Kallas, Esper Georges [UNIFESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Guimarães, Thaís [UNIFESP] Granato, Celso Francisco Hernandes [UNIFESP] Varella, Drauzio [UNIFESP] Ferraz, Maria Lucia Cardoso Gomes [UNIFESP] Castelo Filho, Adauto [UNIFESP] Kallas, Esper Georges [UNIFESP] |
dc.subject.por.fl_str_mv |
HCV seroprevalence prison risk factor |
topic |
HCV seroprevalence prison risk factor |
description |
Hepatitis C virus (HCV) causes infectious hepatitis worldwide. It is transmitted mainly by blood products and sharing of intravenous paraphernalia during illicit drug use. High prevalence rates have been described among specific groups considered to be at higher risk for HCV infection, including prison inmates. The objectives of this study were: to determine the HCV seroprevalence among inmates of Casa de Detenção de São Paulo; to identify risk factors for HCV infection; and to compare the seroprevalence of HCV to other blood borne or sexually transmitted diseases. From December, 1993, to January, 1994, a total of 779 inmates were interviewed to collect information on sociodemographic status, sexual behavior, and past experience with illicit drugs. Blood samples were obtained from 756 inmates for serological tests. 310 (41%) blood samples were positive for anti-HCV, 425 (56.2%) were negative, and 21 (2.8%) showed indeterminate results. In this population, we found a seroprevalence of 13.7% for HIV, 3.3% for syphilis (VDRL), and 68.1% for hepatitis B virus previous infection. Four variables were each identified as associated with a positive anti-HCV serologic test: a positive VDRL (OR = 2.63 IC 95% 1.08 to 6.36); a time of current imprisonment longer than 130 months (OR = 2.44 IC 95% 1.04 to 5.71); previous incarceration at Casa de Detenção de São Paulo (OR = 1.73 IC 95% 1.19 to 2.52) and; illicit drug use before admission to the Casa de Detenção de São Paulo (OR = 1.64 IC 95% 1.15 to 2.33). The seroprevalence of HCV antibodies among the study population was high (41%), indeed, one of the highest clusters of HCV infection recorded until now. Four variables were each shown to be associated with HCV infection. The simultaneous presence of these 4 variables is associated with an 82% probability of being anti-HCV positive. Although risk factor analysis indicates most HCV infections occur prior to inprisonment, initiation of control measures to prevent continued transmission after incarceration should be done. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-06-01 2015-06-14T13:29:25Z 2015-06-14T13:29:25Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1413-86702001000300002 Brazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 5, n. 3, p. 111-118, 2001. 10.1590/S1413-86702001000300002 S1413-86702001000300002.pdf 1413-8670 S1413-86702001000300002 http://repositorio.unifesp.br/handle/11600/1178 |
url |
http://dx.doi.org/10.1590/S1413-86702001000300002 http://repositorio.unifesp.br/handle/11600/1178 |
identifier_str_mv |
Brazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 5, n. 3, p. 111-118, 2001. 10.1590/S1413-86702001000300002 S1413-86702001000300002.pdf 1413-8670 S1413-86702001000300002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Brazilian Journal of Infectious Diseases |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
111-118 application/pdf |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268313967001600 |